National Institute of Environmental Health Sciences (NIEHS)

NIEHS earns WELL building rating amid pandemic

Newswise — On March 30, 2021, the National Institute of Environmental Health Sciences (NIEHS) became the first federal agency to achieve the International WELL Building Institute’s Health-Safety Rating. Throughout the COVID-19 pandemic, NIEHS upgraded facility operations and management practices to protect staff and others who visit the institute’s campus in Research Triangle Park, North Carolina, and those efforts have now earned global recognition.

NIEHS, which is part of the National Institutes of Health (NIH), joins organizations such as JP Morgan Chase and the New York Yankees in receiving the WELL building seal of approval. The WELL rating system is designed to encourage organizations to make workplaces and community spaces as safe and health-promoting as possible. Celebrities including Jennifer Lopez, Venus Williams, and others have kicked-off a major ad campaign to raise awareness about the program.

“At NIEHS, our mission is to discover how the environment affects people in order to promote healthier lives,” said Chris Long, the institute’s associate director for management. “Being awarded the WELL Health-Safety seal shows that we live our mission by creating a work environment that supports health and safety. We’re grateful for the hands-on leadership that our partners in the NIH Office of Research Facilities provided in pursuing this first-ever WELL certification in the federal government.”

The WELL building rating achieved by NIEHS goes beyond the many protective measures undertaken to prevent the spread of COVID-19. It signals the institute’s long-term commitment to maintaining high facility standards in the following areas:

  • Air and water quality management — Assessing ventilation; maintaining air treatment systems; developing Legionella management plan; monitoring air and water quality; and managing mold and moisture on the premises.
  • Cleaning and sanitization procedures — Improving cleaning practices to reduce exposure to pathogens, allergens, and harmful cleaning chemicals; cleaning high-touch surfaces three times per day; and following safety protocols by ensuring strict review of all cleaning products.
  • Emergency preparedness programs — Helping to safely return employees to campus, as needed, during the pandemic; identifying potential effects of relevant hazards on the premises; determining emergency management planning priorities; and providing emergency resources, such as an outdoor notification system, indoor fire alarm system, and defibrillators.
  • Health service resources — Providing annual sick leave and employee health benefits; supporting mental health through crisis counseling, bereavement counseling, and other services; providing free on-site flu vaccination clinic; and promoting a smoke-free workplace.
  • Stakeholder engagement and communication — Conducting monthly institute-wide meetings to share health and safety information; providing weekly updates about the COVID-19 pandemic; sharing food inspection information in the NIEHS cafeteria; and promoting health at the institute and across the U.S.

“Our institute’s health and safety team deserves great credit,” said NIEHS and National Toxicology Program Director Rick Woychik, Ph.D. “We have always enjoyed a clean, well-run research facility, but they found new ways to strengthen our operations in the middle of a pandemic. I’m thrilled that our institute achieved the WELL Health-Safety rating, and I think the progress we have made will benefit our staff and visitors for years to come.”


About the National Institute of Environmental Health Sciences (NIEHS): NIEHS supports research to understand the effects of the environment on human health and is part of the National Institutes of Health. For more information on NIEHS or environmental health topics, visit or subscribe to a news list

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH...Turning Discovery Into Health®

Filters close

Showing results

1120 of 5849
Released: 17-Jun-2021 1:30 PM EDT
Hackensack Meridian Doctors, Student Help Establish Way to Prioritize Surgeries During COVID-19 lockdown
Hackensack Meridian Health

The MeNTS method of prioritizing surgeries during the height of pandemic, developed by University of Chicago, helped procedures continue during time of need

Released: 17-Jun-2021 12:55 PM EDT
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
North Carolina State University

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 21-Jun-2021 11:00 AM EDT Released to reporters: 17-Jun-2021 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Released: 17-Jun-2021 11:55 AM EDT
Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Washington University in St. Louis

A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma — the pale yellow liquid in blood that is rich in antibodies — from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.

Released: 17-Jun-2021 11:05 AM EDT
Stress during pandemic linked to poor sleep
Washington State University

Many people likely lost sleep over COVID-19. A study of twins led by Washington State University researchers found that stress, anxiety and depression during the first few weeks of the pandemic were associated with less and lower quality sleep.

Newswise:Video Embedded university-of-miami-miller-school-study-shows-covid-19-mrna-vaccines-do-not-impact-male-fertility
Released: 17-Jun-2021 11:00 AM EDT
University of Miami Miller School Study Shows COVID-19 mRNA Vaccines Do Not Impact Male Fertility
University of Miami Health System, Miller School of Medicine

The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.

15-Jun-2021 1:20 PM EDT
Higher COVID-19 Mortality Among Black Patients Linked to Unequal Hospital Quality
Perelman School of Medicine at the University of Pennsylvania

If Black patients were admitted to the same hospitals that serve a majority of White patients, researchers showed their risk of death would drop by 10 percent

Released: 17-Jun-2021 9:35 AM EDT
Hackensack Meridian CDI Scientists Develop ‘CATCHER’ for Crucial Biomarkers
Hackensack Meridian Health

The EV-CATCHER methodology identifies and captures tiny pieces of genetic material – and shows value in COVID-19 plasma

Newswise: “ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Released: 17-Jun-2021 8:55 AM EDT
“ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Chulalongkorn University

On June 14, 2021 at Bhumisirimangalanusorn Building, Chulalongkorn Memorial Hospital, the Thai Red Cross Society, the Faculty of Medicine and the Chula Vaccine Research Center (CVRC), Faculty of Medicine, Chulalongkorn University conducted its first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health. The process is continuing on to phase 2 to monitor immunity reactions to the ChulaCov19 vaccine under the supervision of medical experts, doctors, nurses and the research team.

16-Jun-2021 5:00 AM EDT
Disadvantaged Neighborhoods See More COVID-19 Infections and Deaths, Mount Sinai Scientists Report
Mount Sinai Health System

New York City neighborhoods that had higher levels of socioeconomic disadvantage experienced more COVID-19 infections and deaths, according to Mount Sinai scientists who created a neighborhood-level COVID-19 inequity index.

Showing results

1120 of 5849